Details of the Drug

General Information of Drug (ID: DMUGYYL)

Drug Name

IMM-101

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01303172) A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer. U.S. National Institutes of Health.